Market reaction suggests it doesn't share your view. It takes more than good relationships to secure funding for this major fleet expansion.
Financiers look for stong cash flow statements and the contracts that generate the receipts. Cash flow from operations declined 49% from PCP. Receipts up 24%, but problem is payments increased 29%, plus higher interest costs.
Pricoa Private Capital are the major financiers providing a USD100M Shelf Facility (fully drawn). ANZ provide Term Loans and working capital facilities. Management do not have a good track record and it beggars belief they do not have funding in place for this further fleet expansion, and exposed themselves to an Auditors 'Material uncertainty' statement.
If they do secure further funding from Pricoa or elsewhere it won't come cheaply. Perhaps as others have mentioned, a capital raise is the answer.
- Forums
- ASX - By Stock
- AQZ
- Ann: HY24 Results Presentation
Ann: HY24 Results Presentation, page-10
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AQZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.62 |
Change
-0.050(1.87%) |
Mkt cap ! $421.1M |
Open | High | Low | Value | Volume |
$2.73 | $2.73 | $2.61 | $27.96K | 10.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 972 | $2.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.68 | 8000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 972 | 2.620 |
4 | 18403 | 2.610 |
4 | 2584 | 2.600 |
1 | 1950 | 2.560 |
3 | 740 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.680 | 8000 | 1 |
2.700 | 1187 | 2 |
2.710 | 300 | 1 |
2.720 | 699 | 1 |
2.730 | 15501 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AQZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online